UPDATE: Paradigm Capital Reiterates Buy Rating, Raises PT on Celestica
In a report published Wednesday, Paradigm Capital reiterated its Buy rating on Celestica (NYSE: CLS), and slightly raised its price target from $8.50 to $9.00.
Paradigm Capital noted, “We view Celestica as an affordable way to gain broad technology exposure given its industry-low valuation. Furthermore, we believe the company's increasing proportion of revenue from the diversified manufacturing vertical could help drive a multi-year margin expansion story.”
Celestica closed on Tuesday at $7.41.
Latest Ratings for CLS
|Oct 2014||Standpoint Research||Initiates Coverage on||Buy|
© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.